| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, Director | Director, Chairman Of Board
2 companies
Loscalzo Joseph serves as a Director at CYPH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $3.7M at current prices.
Historically, Loscalzo Joseph's trades have earned a below-average insider score of 16/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -92.4%.
The biggest single holding is IONS (~$3.7M) as Director. The recent filings there lean toward selling, a net 122,797 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | IONS Ionis Pharmaceuticals, Inc. | Director | Sale+OE | 77,289 | $75.06 | $5,801,226.23 | -68.0% | - | - | |
| Oct 31, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 16,000 | $75.10 | $1,201,668.80 | -30.6% | +12.9% | - | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 16,000 | $60.15 | $962,371.20 | -30.6% | +34.4% | - | |
| Nov 12, 2024 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 13,508 | $37.86 | $511,426.39 | -29.5% | -16.7% | +92.4% |